Jonathan Megerian, MD, Child Neurology, Orange, CA


Child Neurology Orange, CA


Dr. Megerian is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Megerian's full profile

Already have an account?

Education & Training

  • Boston Children's Hospital
    Boston Children's HospitalFellowship, Child Neurology, 1995 - 1998
  • Boston University Medical Center
    Boston University Medical CenterResidency, Pediatrics, 1993 - 1995
  • Northwestern University Medical SchoolPhD, 1985 - 1993
  • Northwestern University Feinberg School of Medicine
    Northwestern University Feinberg School of MedicineClass of 1993
  • Union CollegeB.S., Biology/Chemistry, Magna Cum Laude, 1981 - 1985

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2015 - 2023
  • FL State Medical License
    FL State Medical License 2012 - 2018
  • MA State Medical License
    MA State Medical License 1995 - 2022
  • American Board of Pediatrics Pediatrics
  • American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology

Awards, Honors, & Recognition

  • Neurological Science Academic Development Award National Institutes of Health, 1995
  • Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

Publications & Presentations


Journal Articles

  • Melatonin Deficiency and Disrupted Circadian Rhythms in Pediatric Survivors of Craniopharyngioma.  
    Lipton J, Megerian JT, Kothare, SV, et al, Neurology, 7/28/2009
  • Utility of Nerve Conduction Studies for Medicine Physicians  
    Megerian, J.T, Kong, X. and Gozani, S. N., J Am Board Fam Med, 1/1/2007
  • "Diabetic Nerve Conduction Abnormalities in the Primary Care Setting"  
    Vinik, A.I., Kong, X, Megerian, J.T., Gozani, S.N., Diabetes Technology & Therapeutics, 12/1/2006
  • Join now to see all


  • Recurrent encephalopathy with coma: An unusual late delayed effect of whole-brain radiotherapy.
    Megerian JT, Paleologos NA, Vick, Am Acad. Neurol, 1/1/1995
  • Delayed Phosphorylation of GAP-43 During Neurite Outgrowth in a Mouse Neuroblastoma Line.
    Megerian, J.T., Meiri, K.F., & Klein, W.L., Soc.Neurosci., 1/1/1991
  • Expression of Tau and ALZ-50 in Human Cortical Cell Line HCN-1A and Non-Human Neuroblastoma Cell Lines.
    Enam, S.A., Megerian, J.T., & Klein, W.L., Soc. Neurosci., 1/1/1991
  • Join now to see all


  • Autism: What Have We Learned and How to Manage 
    Children's Hospital Boston Pediatric Health Care Summit, Beverly, MA - 4/29/2009
  • Alzheimer's Disease Treatment Update: Present and Future 
    Medical Grand Rounds, North Shore Medical Center; Medical Grand Rounds, Union Hospital, Jun 2009 - 3/13/2009
  • Pipeline Projects Session. Results from a Phase 2A clinical study of a novel 5HT4 agonist for the treatment of Alzheimer's Disease. 
    American Society for Experimental Neurotherapeutics Annual Meeting, Arlington, VA - 3/6/2009
  • Join now to see all


  • Results of a Phase 2A Study of PRX-03140 For the Treatment of Alzheimer's disease. 
    Megerian, J.T., Shacham, S, Kalafer, M, and Uprichard, A., ICAD, Blog
    Chicago, IL - 7/1/2008
    Megerian, J. T., Dissertation
    Northwestern University Medical School - 1/1/1993

Grant Support

  • Behavioral Effects Of Dietary Glycemic Index In ADHDNational Center For Research Resources2000–2002

Professional Memberships